Between 15 and 19 April 2019, Swissfillon AG in Visp will face the scrutiny of the FDA – Food and Drug Administration. The inspection authority is the Food and Drug Administration of the USA. It has set itself the task of protecting public health in the United States and, in this context, monitors the safety
West recently announced it has commenced discussions with Swissfillon AG, a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies that are intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customers using West’s proprietary SmartDose drug delivery platform for complex molecules. Through the collaboration, it is anticipated that
Exton, PA—February 6, 2019—West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and Swissfillon AG, a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies, have commenced discussions that are intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customersusing West’s
Pharmaceutical companies that want to complete their products with the highest
quality and safety in the filling process are in good hands with Swissfillon. We fill vials, capsules and disposable syringes under sterile conditions and in outstanding quality. You can concentrate yourselves on your pharmaceutical products, which we fill precisely and reliably. That is our passion.